Cleared Traditional

K201819 - Cadwell Apollo System (FDA 510(k) Clearance)

Sep 2020
Decision
90d
Days
Class 2
Risk

K201819 is an FDA 510(k) clearance for the Cadwell Apollo System. This device is classified as a Full-montage Standard Electroencephalograph (Class II - Special Controls, product code GWQ).

Submitted by Cadwell Industries, Inc. (Kennewick, US). The FDA issued a Cleared decision on September 29, 2020, 90 days after receiving the submission on July 1, 2020.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations.

Submission Details

510(k) Number K201819 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 2020
Decision Date September 29, 2020
Days to Decision 90 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GWQ - Full-montage Standard Electroencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations